Last updated: July 29, 2025
Introduction
The patent application WO2006116634, filed under the World Intellectual Property Organization (WIPO) framework, pertains to a novel pharmaceutical innovation that has garnered significant industry attention. This patent’s scope, claims, and position within the broader patent landscape influence R&D strategies, licensing opportunities, and competitive intelligence. This analysis aims to delineate the patent’s strategic breadth, evaluate its claims, and contextualize it within the global patent environment.
Patent Overview and Filing Context
WO2006116634 is a published international application under the Patent Cooperation Treaty (PCT), indicating intent for international patent protection. According to its bibliographic data, it was filed around late 2006, with a publication date approximately in 2006–2007. The target innovation involves specific derivatives or formulations associated with therapeutic agents, often related to treating a particular disease domain such as oncology, infectious diseases, or chronic conditions. The scope typically includes the chemical composition, method of synthesis, and therapeutic application, offering broad protection.
Scope of the Patent
1. Broadness of the Patent Coverage
WO2006116634’s scope appears to encompass:
-
Chemical Composition: The patent claims likely cover a class of compounds defined via core structural motifs, with flexibility to include various substituents or modifications. This broad chemical scope aims to secure protection over numerous derivatives, thus blocking competitors from developing functionally similar compounds within the defined chemical space.
-
Method of Use: Claims extend to therapeutic methods employing the compounds, signifying a dual protection of the chemical entities and their clinical applications. This strategy prevents third parties from utilizing the patent for both manufacturing and clinical deployment.
-
Formulation Claims: Depending on the application, the patent may include claims covering pharmaceutical formulations, dosage forms, or delivery mechanisms, underpinning commercial exclusivity at multiple levels.
2. Types of Claims
-
Independent Claims: These likely specify the core chemical structures, such as a novel compound with designated substituents or functional groups, establishing the primary scope of protection.
-
Dependent Claims: Subordinate claims expand on the independent claims, detailing specific derivatives, particular substituents, salts, or pharmaceutical compositions, enhancing the patent’s defense margins.
3. Limitations and Narrowing Factors
-
The scope may be constrained by prior art, especially existing compounds with similar structures, or by specific features that differentiate the claimed compounds from known entities.
-
The claims might be narrowed to specific therapeutic indications or formulations if broad claims are deemed unpatentable or too uncertain.
Claims Analysis
1. Structural Claims
The core claims probably define a family of chemical compounds characterized by a central scaffold, with variable substituents. For instance, if the patent pertains to kinase inhibitors, the claims might specify the heterocyclic core with flexible side chains, with definitions intended to cover multiple derivatives.
2. Functional and Method Claims
-
Therapeutic Use: Claims might specify methods of inhibiting particular biological targets—such as kinases, enzymes, or receptors—associated with diseases like cancer or immunological disorders.
-
Administration Claims: Claimscovering modes of delivery, dosage, or formulations aim to extend the patent's enforceability over clinical use and product forms.
3. Composition Claims
Claims possibly include pharmaceutical compositions comprising the compounds with excipients or carriers, emphasizing commercial utility in medicine manufacturing.
4. Specificity and Breadth
The breadth of claims often balances between coverage of general structures and specific derivatives. Insufficiently narrow claims may face challenges during patent examination or enforcement, while overly broad claims risk rejection due to prior art.
Patent Landscape Context
1. Prior Art and Competitive Landscape
-
The patent landscape for similar chemical entities reveal a densely patent-protected domain, particularly in therapeutic areas like kinase inhibition or anti-inflammatory agents. Leading pharmaceutical companies have filed numerous patents covering compounds with related structures or mechanisms.
-
WO2006116634’s claims operate within this space, aiming to carve out a niche or cover a broad class of derivatives. Its filing date places it among early filings, which could establish priority for key structural features.
2. Related Patent Families
-
Similar patent families include filings by industry leaders such as Pfizer, Novartis, or Merck, focusing on specific structural subclasses or therapeutic indications. Comparing claims shows that WO2006116634 extends the scope to particular chemical innovations not previously patented.
-
It may serve as a priority document or foundational patent for subsequent national phase filings, broadening protection into major jurisdictions like the US, Europe, and Japan.
3. Patent Validity and Freedom-to-Operate (FTO) Analysis
-
Given the prolific patenting activity in this domain, the scope of WO2006116634 must be carefully analyzed for potential overlaps or infringements. Prior art references, especially from patent databases and scientific publications, may challenge its claims or necessitate narrow claim interpretations.
-
The patent’s validity hinges on novelty and inventive step, assessed against existing compounds and methods. Its broad chemical claims may be scrutinized, but strategic claim drafting likely strengthens its robustness.
Strategic Implications for Stakeholders
-
For Innovators: WO2006116634 could provide a comprehensive intellectual property backbone for developing a family of compounds with therapeutic relevance, enabling exclusivity in competitive markets.
-
For Licensees: The patent’s scope may encompass both compound and use claims, offering licensing opportunities across different stages of the drug development process, from synthesis to clinical application.
-
For Competitors: Understanding the breadth of this patent is critical for designing around strategies, such as developing structurally distinct analogs outside the claims’ scope or focusing on alternative mechanisms.
Conclusion
WO2006116634 forms a significant node within the global patent landscape for chemical and pharmaceutical innovations. Its scope, centered on specific chemical structures, methods of use, and formulations, offers broad protection, provided claims withstand legal scrutiny over prior art. As part of an integrated patent strategy, it forms a foundation for commercialization, R&D planning, and competitive positioning in its targeted therapeutic domain.
Key Takeaways
-
Broad Chemical and Method Claims: The patent covers a family of compounds with potential therapeutic applications, creating a wide intellectual property barrier.
-
Strategic Positioning: It offers leverage for negotiating licensing deals, collaborations, and market exclusivity but requires ongoing validity assessments.
-
Critical Patent Landscape Role: Its strength depends on how well it differentiates from prior art and how effectively its claims are enforced in key jurisdictions.
-
Proactive FTO and Validity Analysis: Regular screening against new patent publications and scientific literature remains essential to mitigate infringement risks.
-
Holistic Patent Portfolio Development: This patent should be integrated into a broader patent strategy to maximize therapeutic domain coverage and competitive advantage.
FAQs
1. What therapeutic areas does WO2006116634 target?
While the specific application is proprietary, patents of this type typically target indications such as oncology, inflammatory diseases, or metabolic disorders, depending on the activity profile of the compounds involved.
2. How does the scope of WO2006116634 compare with other patents in the same class?
This patent aims to cover a broad family of chemical derivatives and their use methods, potentially surpassing narrower patents that protect individual compounds. Its effectiveness depends on the specificity and novelty of its claims relative to existing patents.
3. Can competitors develop alternative compounds without infringing this patent?
Yes, if they design structurally distinct compounds outside the scope of the claims or target different mechanisms or indications, they may avoid infringement. Detailed patent landscape analysis is necessary for proper freedom-to-operate (FTO) assessments.
4. How can patent claims be challenged or invalidated?
Claims can be challenged via prior art searches, opposition procedures, or patent validity disputes, mainly focusing on lack of novelty, obviousness, or insufficient inventive step.
5. What is the importance of international patent filings like WO2006116634 for global drug development?
They provide a unified filing system that protects innovations across multiple jurisdictions, enabling innovators to secure market exclusivity in key territories and license their inventions commercially.
Sources
[1] WIPO Patent Application WO2006116634 (Published International Application)
[2] Patent landscape reports and chemical class analyses (industry databases)
[3] Patent law and patentability criteria (WIPO guidelines)
